Also trades as: 4507.T (JPX) · $vol 48M · SGIOY (OTC) · $vol 1M

$16.44

+0.05 (+0.31%)

Weekly Expected Move ±3.7%

$15 $16 $16 $17 $18

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 36 · $14.0B mcap · 668M float · 0.0001% daily turnover · Short 68% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$502.8B +14.7% ▲

5Y CAGR: +11.1%

Gross Profit

$413.7B +10.5% ▲

5Y CAGR: +11.1%

Operating Income

$162.4B +3.7% ▲

5Y CAGR: +6.7%

Net Income

$206.5B +21.1% ▲

5Y CAGR: +13.0%

EPS (Diluted)

$242.87 -59.6% ▼

5Y CAGR: -7.8%

EBITDA

$189.5B -17.8% ▼

5Y CAGR: +3.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$335.1B	$426.7B	$435.1B	$438.3B	$502.8B
YoY Growth	+12.8%	+27.3%	+2.0%	+0.7%	+14.7%
Cost of Revenue	$55.4B	$62.2B	$57.6B	$63.8B	$89.1B
Gross Profit	$279.7B	$364.4B	$377.5B	$374.4B	$413.7B
Gross Margin	83.5%	85.4%	86.8%	85.4%	82.3%
R&D Expenses	$73.0B	$102.4B	$102.6B	$108.6B	$123.6B
SG&A Expenses	$91.8B	$97.8B	$99.7B	$101.9B	$127.7B
Operating Expenses	$169.4B	$215.4B	$224.2B	$217.8B	$251.3B
Operating Income	$110.3B	$149.0B	$153.3B	$156.6B	$162.4B
Operating Margin	32.9%	34.9%	35.2%	35.7%	32.3%
Interest Expense	$841M	$4.5B	$6.7B	$9.0B	$8.7B
Income Before Tax	$126.3B	$220.3B	$198.3B	$200.8B	$240.4B
Tax Expense	$12.8B	$35.8B	$37.7B	$31.2B	$33.2B
Net Income	$114.2B	$185.0B	$162.0B	$170.4B	$206.5B
Net Margin	34.1%	43.3%	37.2%	38.9%	41.1%
EPS (Diluted)	$378.62	$621.09	$558.32	$600.98	$242.87
EBITDA	$143.5B	$242.0B	$223.3B	$230.7B	$189.5B
Shares Outstanding	302M	298M	290M	284M	851M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$106.3B	$98.3B	$97.6B	$761M	$101.5B	$100.3B	$114.8B	$147.8B
Cost of Revenue	$14.5B	$16.3B	$14.4B	$108M	$18.1B	$12.9B	$17.7B	$25.7B
Gross Profit	$91.8B	$82.0B	$83.1B	$653M	$83.3B	$87.4B	$97.1B	$122.2B
Gross Margin	86.3%	83.4%	85.2%	85.8%	82.1%	87.2%	84.6%	82.6%
R&D Expenses	$25.4B	$30.0B	$29.4B	$144M	$28.3B	$25.0B	$27.9B	$29.9B
SG&A Expenses	$24.1B	$28.0B	$24.0B	$162M	$27.8B	$25.9B	$28.0B	$35.5B
Operating Expenses	$51.1B	$58.0B	$55.0B	$306M	$56.1B	$51.0B	$55.9B	$65.4B
Operating Income	$40.6B	$24.0B	$28.1B	$347M	$27.2B	$36.4B	$41.2B	$56.8B
Operating Margin	38.2%	24.4%	28.8%	45.6%	26.8%	36.4%	35.9%	38.4%
Interest Expense	$3.1B	$2.7B	$2.8B	$5M	$2.6B	$2.3B	$1.9B	$1.6B
Income Before Tax	$48.9B	$33.8B	$36.9B	$395M	$43.5B	$46.6B	$52.8B	$93.0B
Tax Expense	$12.6B	-$340M	$6.2B	$74M	$8.4B	$7.0B	$8.0B	$18.2B
Net Income	$36.6B	$34.8B	$30.6B	$322M	$35.5B	$39.5B	$44.8B	$74.7B
Net Margin	34.5%	35.4%	31.4%	42.4%	35.0%	39.4%	39.0%	50.6%
EPS (Diluted)	$126.89	$122.20	$108.03	$0.38	$42.00	$46.00	$52.65	$87.83
EBITDA	$56.6B	$41.4B	$33.0B	$434M	$51.1B	$53.9B	$59.9B	$100.6B
Shares Outstanding	289M	285M	284M	851M	851M	851M	851M	851M

SGIOF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet